Dunhill Financial’s enVVeno Medical NVNO Stock Holding History

Dunhill Financial’s Portfolio NVNO Stock Details NVNO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-143	Closed	-$16.8K	–	949
2024 Q3	$16.8K	Buy	+143	New	+$26.3K	0.01%	296

Other funds holding NVNO

KCM

Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return

NCM

Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

ACM

Altium Capital Management New York $42M AUM

UOC

UBS O'Connor Chicago, Illinois $3.38B AUM 63.08% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return

WIM

Westside Investment Management Santa Monica, California $653M AUM 28.36% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Dunhill Financial's NVNO Position: Q4 2024 in Review

Dunhill Financial sold out of enVVeno Medical (NVNO) in Q4 2024, closing a stake of 143 shares — an estimated $16.8K sold.

Dunhill Financial first reported a position in NVNO in Q3 2024 and held it in 1 quarter. The position peaked at $16.8K in Q3 2024. 34 funds tracked by Wall St. Rank hold NVNO as of Q4 2024.

Dunhill Financial reported no remaining enVVeno Medical position as of Q4 2024 after selling out during the quarter.
Dunhill Financial sold 143 enVVeno Medical shares in Q4 2024, an estimated $16.8K.
Dunhill Financial first reported a position in enVVeno Medical in Q3 2024 and held it in 1 quarter.
Dunhill Financial's enVVeno Medical position peaked at $16.8K in Q3 2024.
34 funds tracked by Wall St. Rank held enVVeno Medical as of Q4 2024.

Based on Dunhill Financial's 13F filing for Q4 2024, filed 14 Feb 2025.